October 28, 2016
AstraZeneca pauses two cancer drug trials’ enrolment due to bleeding
AstraZeneca’s high hopes for cancer immunotherapy were dented on Thursday as the recruitment
Pharmaceuticals, Biotechnology and Life Sciences
Tag: Richard Parkes